Matrix Metalloproteinase Inhibitor Drugs
- 1 June 1997
- journal article
- Published by Taylor & Francis in Emerging Drugs
- Vol. 2 (1) , 205-230
- https://doi.org/10.1517/14728214.2.1.205
Abstract
(1997). Matrix Metalloproteinase Inhibitor Drugs. Emerging Drugs: Vol. 2, No. 1, pp. 205-230. doi: 10.1517/14728214.2.1.205Keywords
This publication has 26 references indexed in Scilit:
- Matrix Metalloproteinases, Gelatinase and Collagenase, in Chronic Leg UlcersJournal of Investigative Dermatology, 1996
- A Pilot Study of Clostridium Collagenase (Collagenase ABC®) Ointment in the Debridement of Dermal UlcersClinical Drug Investigation, 1996
- Determination of metalloproteinases, plasminogenactivators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesisClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Review Oncologic, Endocrine & Metabolic: Recent developments in matrix metalloproteinase inhibitorsExpert Opinion on Therapeutic Patents, 1995
- Transcriptional Regulation of the Collagenase Gene by Basic Fibroblast Growth Factor in Osteoblastic MC3T3-E1 CellsBiochemical and Biophysical Research Communications, 1995
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Induction of metalloproteinase activity, cartilage matrix degradation and inhibition of endochondral mineralization in vitro byE. colilipopolysaccharide is mediated by interleukin 1αCytokine, 1995
- Plasma Assay of Matrix Metalloproteinases (MMPs) and MMP-Inhibitor Complexes in Cancer.Annals of the New York Academy of Sciences, 1994
- Role of TIMP and MMP Inhibition in Preventing Connective Tissue BreakdownAnnals of the New York Academy of Sciences, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994